What is Aristo Bio-Tech and Lifescience EV-to-Revenue?
Aristo Bio-Tech and LifescienceNSE:ARISTO 60 EV-to-Revenue is 0.28 as of Jun. 24, 2026, which is 10% below its 10-year median of 0.31. GuruFocus rates NSE:ARISTO with a GF Score™ of 60/100. The stock has 2 warning signs investors should review. Among 250 Agriculture companies, Aristo Bio-Tech and Lifescience ranks better than 92.4% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Aristo Bio-Tech and Lifescience's enterprise value is ₹886 Mil.
Aristo Bio-Tech and Lifescience's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,181 Mil. Therefore, Aristo Bio-Tech and Lifescience's EV-to-Revenue for today is 0.28.
The historical rank and industry rank for Aristo Bio-Tech and Lifescience's EV-to-Revenue or its related term are showing as below:
NSE:ARISTO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.23 Med: 0.31 Max: 0.53
Current: 0.28
During the past 6 years, the highest EV-to-Revenue of Aristo Bio-Tech and Lifescience was 0.53. The lowest was 0.23. And the median was 0.31.
NSE:ARISTO's EV-to-Revenue is ranked better than 92.4% of 250
companies
in the Agriculture industry
Industry Median: 1.215
vs NSE:ARISTO: 0.28
Aristo Bio-Tech and Lifescience's share price for today is ₹99.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Mar. 2025 was ₹467.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience EV-to-Revenue Related Terms
Aristo Bio-Tech and Lifescience EV-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience EV-to-Revenue Chart
For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aristo Bio-Tech and Lifescience EV-to-Revenue vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Aristo Bio-Tech and Lifescience's EV-to-Revenue falls into.
Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹886 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,181 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a EV-to-Revenue of 0.28 as of Jun. 24, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Aristo Bio-Tech and Lifescience and its competitors. This is 10% below median its historical median of 0.31. Over the past decade, Aristo Bio-Tech and Lifescience's EV-to-Revenue has ranged from 0.23 to 0.53. According to the industry distribution chart, Aristo Bio-Tech and Lifescience ranks #19 out of 250 companies in the Agriculture industry, placing it in the top 7.6%.
Is Aristo Bio-Tech and Lifescience's EV-to-Revenue too high?
Aristo Bio-Tech and Lifescience's current EV-to-Revenue of 0.28 is 10% below median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 0.53. The Agriculture industry median EV-to-Revenue is 1.22. Aristo Bio-Tech and Lifescience's value of 0.28 is 77% below this industry median. Based on the distribution chart, Aristo Bio-Tech and Lifescience ranks #19 out of 250 companies in the Agriculture industry, which is in the top quartile — a strong position relative to peers. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's EV-to-Revenue compare to CTVA and CF?
According to the Agriculture industry distribution chart, Aristo Bio-Tech and Lifescience ranks #19 out of 250 companies for EV-to-Revenue. This places Aristo Bio-Tech and Lifescience in the top 8% of its industry — outperforming the majority of peers. The industry median EV-to-Revenue is 1.22. Aristo Bio-Tech and Lifescience's value of 0.28 is 77% below this benchmark. Historically, Aristo Bio-Tech and Lifescience's own EV-to-Revenue has ranged from 0.23 to 0.53 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 1.22, Aristo Bio-Tech and Lifescience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for an Agriculture company?
The median EV-to-Revenue among Agriculture companies is 1.22, based on 250 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aristo Bio-Tech and Lifescience's current EV-to-Revenue of 0.28 is 77% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Aristo Bio-Tech and Lifescience and its competitors. For the Agriculture industry, the median EV-to-Revenue is 1.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aristo Bio-Tech and Lifescience's current EV-to-Revenue is 0.28, which is 10% below median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current EV-to-Revenue of 0.28. The current EV-to-Revenue is 0.28, which is 10% below median its 10-year median of 0.31 and 77% below the Agriculture industry median of 1.22. Aristo Bio-Tech and Lifescience's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current EV-to-Revenue is 0.28 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aristo Bio-Tech and Lifescience Business Description
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
60GF Score
Get the complete analysis for NSE:ARISTO
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ARISTO has been successfully added to your 
